DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 86 filers reported holding DESIGN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $18,718,755 | +9.2% | 2,971,231 | 0.0% | 0.35% | -9.0% |
Q1 2023 | $17,144,003 | -43.8% | 2,971,231 | 0.0% | 0.39% | -37.2% |
Q4 2022 | $30,484,830 | -34.3% | 2,971,231 | +7.1% | 0.62% | -37.5% |
Q3 2022 | $46,368,000 | +51.5% | 2,773,231 | +26.8% | 0.99% | +21.2% |
Q2 2022 | $30,613,000 | -13.3% | 2,186,636 | 0.0% | 0.82% | +5.8% |
Q1 2022 | $35,314,000 | -24.6% | 2,186,636 | 0.0% | 0.77% | -6.5% |
Q4 2021 | $46,816,000 | +45.7% | 2,186,636 | 0.0% | 0.82% | +85.4% |
Q3 2021 | $32,122,000 | -26.1% | 2,186,636 | 0.0% | 0.44% | -36.2% |
Q2 2021 | $43,492,000 | -33.5% | 2,186,636 | 0.0% | 0.70% | -29.2% |
Q1 2021 | $65,380,000 | – | 2,186,636 | – | 0.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |